Key result
Vaccination with recombinant rLaSota/VP2 provided 90% protection against NDV and 80% protection against IBDV after primary vaccination, and complete protection against both viruses after booster immunization.
Why the study?
Does a recombinant NDV expressing IBDV VP2 protein protect chickens against NDV and IBDV challenge?
Does a recombinant NDV expressing IBDV VP2 protein protect chickens against NDV and IBDV challenge?
This is the authors' abstract. We don't add key points for this paper.
Infectious bursal disease virus (IBDV) causes a highly immunosuppressive disease in chickens. Currently available, live IBDV vaccines can lead to generation of variant viruses. We have developed an alternative vaccine that will not create variant IBDV. By using the reverse genetics approach, we devised a recombinant Newcastle disease virus (NDV) vector from a commonly used vaccine strain LaSota to express the host-protective immunogen VP2 of a variant IBDV strain GLS-5. The gene encoding the VP2 protein of the IBDV was inserted into the most 3'-proximal locus of a full-length NDV cDNA for high-level expression. We successfully recovered the recombinant virus, rLaSota/VP2. The rLaSota/VP2 was genetically stable, at least up to 12 serial passages in chicken embryos, and was shown to express the VP2 protein. The VP2 protein was not incorporated into the virions of recombinant virus. Recombinant rLaSota/VP2 replicated to a titer similar to that of parental NDV strain LaSota in chicken embryos and cell cultures. To assess protective efficacy of the rLaSota/VP2, 2-day-old specific-pathogen-free chickens were vaccinated with the recombinant virus and challenged with a highly virulent NDV strain Texas GB or IBDV variant strain GLS-5 at 3 weeks postvaccination. Vaccination with rLaSota/VP2 generated antibody responses against both NDV and IBDV and provided 90% protection against NDV and IBDV. Booster immunization induced higher levels of antibody responses against both NDV and IBDV and conferred complete protection against both viruses. These results indicate that the recombinant NDV can be used as a vaccine vector for other avian pathogens.
Answers are grounded in this paper and cite their sources.
A recombinant NDV vector expressing the IBDV VP2 protein is a viable bivalent vaccine candidate that protects chickens against both NDV and IBDV.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2004) studied Newcastle disease and infectious bursal disease (n=130). rLaSota/VP2 (Recombinant NDV expressing IBDV VP2 protein) vs. Unvaccinated control, commercial NDV vaccine, or commercial IBDV vaccine was evaluated on Protection against virulent IBDV strain GLS-5 challenge after primary vaccination. Vaccination with recombinant rLaSota/VP2 provided 90% protection against NDV and 80% protection against IBDV after primary vaccination, and complete protection against both viruses after booster immunization.
Synapse has enriched 10 related papers. Consider them for comparative context: